Adam Nowakowski
Overview
Explore the profile of Adam Nowakowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
399
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malcher A, Stokowy T, Berman A, Olszewska M, Jedrzejczak P, Sielski D, et al.
Andrology
. 2022 Aug;
10(8):1605-1624.
PMID: 36017582
Background: Genetic causes that lead to spermatogenetic failure in patients with nonobstructive azoospermia (NOA) have not been yet completely established. Objective: To identify low-frequency NOA-associated single nucleotide variants (SNVs) using...
2.
Drela K, Stanaszek L, Nowakowski A, Kuczynska Z, Lukomska B
Stem Cells Int
. 2019 Apr;
2019:7012692.
PMID: 30956673
Mesenchymal stem cells (MSCs) are attractive candidates for cell-based tissue repair approaches. Hundreds of clinical trials using MSCs have been completed and many others are still being investigated. For most...
3.
Andrzejewska A, Nowakowski A, Grygorowicz T, Dabrowska S, Orzel J, Walczak P, et al.
J Cereb Blood Flow Metab
. 2018 Oct;
39(11):2308-2320.
PMID: 30362860
Therapeutic potential of mesenchymal stem cells (MSCs) has been reported consistently in animal models of stroke, with mechanism mainly through immunomodulation and paracrine activity. Intravenous injection has been a prevailing...
4.
Nowakowski A, Andrzejewska A, Boltze J, Nitzsche F, Cui L, Jolkkonen J, et al.
Sci Rep
. 2017 Apr;
7(1):1103.
PMID: 28439079
Mesenchymal stem cells (MSCs) represent promising resource of cells for regenerative medicine in neurological disorders. However, efficient and minimally invasive methods of MSCs delivery to the brain still have to...
5.
Walczak P, Wojtkiewicz J, Nowakowski A, Habich A, Holak P, Xu J, et al.
J Cereb Blood Flow Metab
. 2016 Sep;
37(7):2346-2358.
PMID: 27618834
Stem cell therapy for neurological disorders reached a pivotal point when the efficacy of several cell types was demonstrated in small animal models. Translation of stem cell therapy is contingent...
6.
Nowakowski A, Drela K, Rozycka J, Janowski M, Lukomska B
Stem Cells Dev
. 2016 Jul;
25(20):1513-1531.
PMID: 27460260
Cell-based gene therapy holds a great promise for the treatment of human malignancy. Among different cells, mesenchymal stem cells (MSCs) are emerging as valuable anti-cancer agents that have the potential...
7.
Nowakowski A, Walczak P, Lukomska B, Janowski M
Stem Cells Int
. 2016 Jun;
2016:4956063.
PMID: 27242906
Mesenchymal stem cells (MSCs) are very attractive for regenerative medicine due to their relatively easy derivation and broad range of differentiation capabilities, either naturally or induced through cell engineering. However,...
8.
Andrzejewska A, Nowakowski A, Janowski M, Bulte J, Gilad A, Walczak P, et al.
Int J Nanomedicine
. 2015 Sep;
10:5543-59.
PMID: 26366076
Therapeutic interventions based on the transplantation of stem and progenitor cells have garnered increasing interest. This interest is fueled by successful preclinical studies for indications in many diseases, including the...
9.
Nowakowski A, Walczak P, Janowski M, Lukomska B
Stem Cells Dev
. 2015 Jul;
24(19):2219-42.
PMID: 26140302
Mesenchymal stem cells (MSCs), which can be obtained from various organs and easily propagated in vitro, are one of the most extensively used types of stem cells and have been...
10.
Cui L, Kerkela E, Bakreen A, Nitzsche F, Andrzejewska A, Nowakowski A, et al.
Stem Cell Res Ther
. 2015 May;
6:11.
PMID: 25971703
Introduction: Intra-arterial cell infusion is an efficient delivery route with which to target organs such as the ischemic brain. However, adverse events including microembolisms and decreased cerebral blood flow were...